Peptides: what they are, how they work and how they are classified

Peptides are molecules made up of amino acids linked by peptide bonds. Some participate in communication between cells, others take part in defence against microorganisms, and yet others are formed during the processing or breakdown of larger proteins. The word „peptide” describes a broad category of molecules — it does not mean one specific substance with one specific function.

Scientific research clearly shows this enormous diversity. Among other things, researchers analysed a naturally occurring human gut hormone, a cyclic peptide isolated from a plant, and small peptide fragments detected in the blood after the consumption of a protein hydrolysate. Therefore, to properly understand such molecules, it is not enough to know that they are „peptides”. Their amino acid sequence, molecular structure, origin, chemical modifications, biological context, and the experimental methods used to study them are also important. [1] [2] [3]

This diversity also explains why general statements such as „peptides do X” can be misleading. Two molecules can both belong to peptides and yet differ significantly in length, shape, stability, biological target, cellular location and function. Results concerning one peptide cannot automatically be transferred to another just because both belong to the same category of molecules.

In this article, we explain the fundamentals of peptide chemistry, their roles in biological systems, and the various ways they can be classified. We also distinguish between what was directly measured in individual studies and broader conclusions that would require additional evidence for confirmation.

What are peptides?

Peptides are linked amino acids

Amino acids are the fundamental units from which peptides and proteins are formed. When they are joined by peptide bonds, they form a single molecule rather than a mixture of separate components. Each amino acid unit incorporated into such a molecule is called amino acid residue.

This can be compared to letters forming a word. The individual letters are the building blocks, but only their specific sequence creates a particular word. Similarly, a peptide is defined by the sequence of its amino acid residues as well as the bonds and modifications that form its full structure. Knowing merely which amino acids are present is not enough to establish the identity of the molecule.

Two peptides, for example, can contain the same set of amino acids, but have them arranged in a different order. They will then constitute different molecular sequences and may have distinct physical, chemical or biological properties.

The formation of a peptide bond is a chemical process studied experimentally. Stachelhaus and co-workers analysed how the elements of enzymes involved in non-ribosomal peptide synthesis formed a product consisting of two residues. Altering the proposed catalytic site prevented the condensation reaction in the experimental system studied. The study shows that peptide formation requires a specific chemical mechanism — amino acids do not form a defined peptide simply because they are adjacent to each other. [4]

Appointment Peptide it therefore refers to the combined chemical structure. It should not be used as a synonym for amino acids, protein supplement or any mixture of substances containing amino acids.

Peptide, polypeptide and protein — related concepts

The term „peptide” is usually used to refer to a relatively short amino acid chain. „Polypeptide” emphasises the presence of a chain containing many amino acid residues, whereas „protein” generally means a biological molecule made up of one or more polypeptide chains.

These concepts partially overlap and there is no single universally accepted number of amino acid residues that constitutes an absolute boundary between them.

This is shown by the scientific literature itself. Saether and co-workers described kalata B1 as a 29-residue „polypeptide”, whereas Mierke and co-workers studied the 36-residue human neuropeptide Y. A molecule does not completely change its chemistry just because one author refers to it as a peptide and another as a polypeptide. [2] [5]

Some educational materials use approximate numerical values to separate peptides and proteins. Such simplifications can be useful during learning, but they should not be treated as an absolute chemical law. The terminology used is also influenced by the molecule's folding, biological processing, function and historical naming convention.

Therefore, in a precise description, the actual sequence and number of amino acid residues are often more informative than the name of the category itself. Nor should the distinction between a peptide and a protein be treated as a hierarchy of complexity, biological significance, potency or research quality.

A short peptide can exhibit very specific biological activity, whereas a much larger protein may perform a completely different structural or enzymatic function. The length of the molecule is only one of its features.

The term „peptide” alone does not tell you how the molecule works

Not all peptides are hormones, antimicrobial substances, signalling molecules, therapeutic substances, or exhibit biological activity in the same way. These are additional properties that must be demonstrated for specific molecules.

Even within a single research area, very similar sequences can behave differently.

For example, in experiments comparing the full systemin molecule—a plant signalling peptide—with its shorter fragments, it was found that the fragments did not reproduce the responses observed for the full peptide. Indeed, one of the fragments acted in direct opposition to it in the tested systems. This serves as a direct reminder that results concerning a full molecule cannot be automatically extrapolated to a fragment of it simply because it shares a similar name. [6]

The same principle applies more broadly. The change of a single amino acid residue, the shortening of the sequence, the modification of the terminal group, the cyclisation of the molecule or the introduction of another chemical modification can alter the behaviour of the peptide.

Therefore, from a scientific point of view, the most useful question is rarely simply:

„What do peptides do?”

A much more precise question is:

„What does this specific peptide of defined sequence and structure do under given experimental conditions?”

This distinction is fundamental to the correct interpretation of peptide research.

What are peptides made of?

Amino acid residues and peptide backbone

Peptides contain a backbone formed of linked amino acid residues. In a typical peptide bond, the carbonyl carbon atom originating from the carboxyl group of one amino acid is bonded to the nitrogen atom originating from the amino group of the second amino acid.

Each amino acid residue also contributes a side chain, often represented in chemical notation as Group R, which helps determine the properties of the molecule.

Side chains are not merely interchangeable accessories. Differences in electrical charge, polarity, size, hydrophobicity, aromatic character and chemical reactivity influence the behaviour of the peptide in solution and its interactions with other molecules.

The structure of a peptide therefore includes both a repeating backbone and chemically diverse groups attached to it.

Some side chains can form additional interactions within the same molecule or with surrounding molecules. These interactions can affect folding, solubility, molecular recognition, interaction with membranes, and other experimentally measurable properties.

Research on LL-37, a human host defence peptide, analysed the relationship between its sequence, folding, self-organisation and membrane interactions. Comparison with a related rhesus peptide revealed distinct behaviour under the studied conditions. The results highlight the importance of the details of molecular structure rather than assuming that similar peptides must act identically. [7]

Peptide direction: N-terminus and C-terminus

A typical linear peptide has two chemically distinct ends.

To the end denotes the amino terminus of the chain, whereas C-end — its carboxyl terminus.

Peptide sequences are conventionally written from the N-terminus to the C-terminus. This direction is important because reversing the order of the residues leads to the formation of a different molecular sequence.

For example, the hypothetical peptide Ala-Gly-Ser is not chemically identical to Ser-Gly-Ala, even though both contain alanine, glycine and serine.

This convention enables scientists to record sequences consistently and is particularly important when comparing peptides, their fragments, precursor sequences, and synthetic variants.

Terminal groups of the molecule can also undergo chemical modifications. If such modifications occur, they should be included in the peptide description, as the chemistry of its termini can influence the properties of the molecule.

Sequence and three-dimensional structure

Sequence determines the order of amino acid residues in a peptide. The three-dimensional structure, on the other hand, describes how this linked molecule is arranged in space. These are related pieces of information, but they do not mean the same thing.

The sequence informs which residues are connected to each other and in what order. Structural analysis can additionally reveal folding, turns, helices, loops, rings, disulphide bridges and other spatial features.

Mierke et al. carried out the chemical synthesis of human neuropeptide Y and subsequently analysed its conformation using several methods, including nuclear magnetic resonance spectroscopy. The structural studies were conducted in a specific solvent mixture. Therefore, the results describe the peptide under these particular conditions and should not be presented as evidence that the molecule adopts the exact same structure in every biological environment. [5]

Peptide conformation can depend, amongst other things, on solvent composition, temperature, pH, ionic environment, concentration, the presence of other molecules, and the membrane environment.

A full scientific description may therefore require the provision of the sequence, chemical modifications, experimental environment and measurement method used.

The amino acid sequence record alone does not contain all the information obtained from structural studies.

Linear chains, rings and additional connections

Not all peptides have an open backbone. Some form a closed ring, while others contain additional connections between the side chains of amino acids.

The term „linear” denotes an open connection architecture, not that the molecule must remain physically straight in space. A linear peptide can bend, fold, and adopt ordered conformations.

Cyclic peptides contain a covalently closed structure. The method of ring formation can vary between individual molecules.

Peptides may also contain disulphide bonds, i.e. covalent bonds that usually form between cysteine residues. Such bonds can restrict possible spatial arrangements and participate in the organisation of the structure.

Kalata B1 is a good example of such an architecture. Scientists isolated it from a plant Oldenlandia affinis, determined its 29 amino acid residues, and confirmed the cyclic nature of the backbone using studies utilising enzymatic cleavage. They also analysed its three-dimensional organisation and disulphide bonds. [2]

These results describe the architecture of this specific peptide. They do not prove that cyclic peptides are generally more active, stable, biologically important or useful than linear peptides.

Peptides can be formed from larger precursors

A biologically active peptide is not always formed immediately in its final form. The cell may first produce a larger precursor molecule, which is then subject to further processing, including cleaving and the removal of specific fragments.

This means that during the formation of the final peptide, several related molecular forms may be present.

Proinsulin illustrates this principle well. A review of analytical methods describes the conversion of proinsulin into insulin and C-peptide via intermediate forms. It also explains why laboratory methods must distinguish between closely related precursors and processed molecules, rather than treating them as a single parameter. [8]

Primary experimental studies provide a more detailed example. Davidson and Hutton isolated from rat insulinoma tissue an enzyme capable of removing basic amino acid residues from substrates derived from proinsulin, leading to the production of insulin. In the assay used, the enzyme did not cause further breakdown of mature insulin. The result supports the concept of selective processing, although the tissue source and the laboratory nature of the experiment limit the possibility of a broader interpretation of a single study. [9]

Precursor processing reveals another important principle: related molecules participating in a single biological pathway should not automatically be treated as interchangeable. The precursor, intermediate form, cleavage fragment and mature product may have different structures and biological properties.

How are peptides formed?

Peptides can be formed through several different biological and laboratory processes.

In many biological systems, precursor molecules containing peptide sequences are formed by ribosomal translation, during which the genetic information ultimately determines the sequence of amino acids in the emerging chain. The resulting precursor may then undergo enzymatic cleavage and other post-translational modifications.

Other peptides are formed in the process non-ribosomal peptide synthesis, in which specialised enzyme systems combine amino acid-derived components without utilising the ribosome in the traditional manner. The research by Stachelhaus and co-workers provides an experimental example of the analysis of the bond formation mechanism in such a system. [4]

Peptides can also be produced in the laboratory by chemical synthesis. This enables scientists to prepare specific sequences for structural, biochemical, analytical and other experiments.

The method of production describes the pathway by which a molecule is formed. However, in itself, it does not determine whether a peptide is biologically active, clinically useful, naturally occurring, or suitable for a specific application.

What role do peptides play in the body?

There is no single function common to all peptides.

The biological role of a specific peptide depends on its sequence, structure, concentration, localisation, molecular target, processing pathway and surrounding biological environment.

Some peptides transmit signals between cells

Some peptides act as biological messengers. Their action depends on the cells receiving the signal and the presence of appropriate molecular systems capable of responding to it.

The signal is therefore not exclusively a property of the peptide itself — the surrounding biological context also matters.

In a human study, Kreymann and co-workers analysed GLP-1 7-36 amide, a gut-derived peptide. The researchers detected it in intestinal tissue, observed changes in its blood concentration following the ingestion of nutrients, and analysed insulin-related responses during controlled infusion experiments. These observations helped to establish the physiological signalling role of this specific peptide. However, they do not imply that peptides as a whole group regulate blood glucose concentrations. [1]

This distinction is important. Evidence confirming the hormonal function of one peptide cannot be generalised to all molecules containing peptide bonds.

Some peptides take part in the defence of the organism

Peptides can also interact with microorganisms or biological membranes.

LL-37 is an example of a peptide studied in the context of human defence mechanisms. Experiments have analysed, amongst other things, its self-organisation and interactions with various membrane environments.

Research by Xhindoli et al. linked the structural behavior of the peptide to differences in membrane interaction and bacterial membrane permeability. This is mechanistic evidence — it helps to understand the behavior of the molecule in experimental systems. In itself, however, it is not a clinical study demonstrating the effect of a product containing LL-37 in humans. [7]

Defence-related peptides are a good illustration of why molecular context matters. Activity observed against a microorganism or model membrane under laboratory conditions does not automatically equate to efficacy, safety or clinical usefulness in humans.

Some peptides perform intracellular biochemical functions

Not every peptide acts as a signal transmitted from one cell to another.

Glutathione is an intracellular tripeptide involved in redox reactions, which are biochemical processes associated with the transfer of electrons.

Cabral and co-workers studied glutathione synthesis in rabbits using labelled water and mass spectrometry. Their work focused on measuring how this molecule is formed and renewed. It shows the peptide participating in intracellular metabolism rather than a hormone transmitting signals between organs. This was a methodological study in animals, not evidence regarding the effects of taking a product containing glutathione. [10]

Glutathione also shows why peptide length does not determine its biological importance. It consists of only three amino acid residues, yet it participates in fundamental chemical processes taking place within cells.

Some peptides are processing or degradation products

Merely detecting a peptide in a biological sample does not automatically explain why it is there.

It can act as a signalling molecule, be an intermediate product of a processing pathway, or be formed as a result of the breakdown of a larger molecule.

Proinsulin assays distinguish between precursor molecules, intermediate products and end products. Food studies, on the other hand, have demonstrated the presence of peptide fragments in the blood following the ingestion of gelatin hydrolysates. These are very different biological contexts, even though both concern peptides. [8] [3]

The detected fragment should therefore be interpreted in relation to its source, structure, concentration, time of occurrence and research question.

Detection of a molecule is proof of its presence. It is not automatically proof of its biological function.

This distinction is particularly important when interpreting analytical studies identifying peptides in blood, tissues, food samples and other complex biological materials.

What do these studies show — and what do they not prove?

Different types of research answer different scientific questions.

Structural methods can characterise the structure of a molecule. Biochemical experiments allow the analysis of molecular reactions and interactions. Animal studies make it possible to observe biological processes in the whole organism. Physiological studies involving humans can measure specific responses in participants.

Types of such evidence can complement each other, but they are not interchangeable.

The most important rule is that the strength and significance of evidence depend on the question we are trying to answer.

The mass spectrometry result identifying the peptide answers a different question to the cellular experiment showing receptor activity. Both of these, in turn, answer different questions to a controlled human study measuring a physiological or clinical effect.

How are peptides classified?

Peptides can be classified in several ways simultaneously. There is no single classification system that encompasses all their important characteristics.

Classification by number of amino acid residues

Length-based names specify the number of amino acid residues in the peptide.

Dipeptide contains two residues, tripeptide three, tetrapeptide four, and pentapeptide five.

Terms such as oligopeptide i polypeptide describe broader groups in terms of size, but their boundaries may vary between sources.

These names do not allow the function of the molecule to be predicted.

A tripeptide can participate in intracellular metabolism, whereas a longer peptide can act as a signalling molecule or adopt a compact cyclic structure. Glutathione, neuropeptide Y and kalata B1 show different combinations of length and biological context. [10] [5] [2]

The length therefore answers the question:

„How many amino acid residues are there in a molecule?”

It does not, however, answer the question on its own:

„How does this molecule work?”

Classification by structure

Structural descriptions include, amongst others, open-chain peptides, cyclic peptides and structures containing disulphide bridges.

Researchers may also describe specific folding patterns, cross-links or chemical modifications, provided these have been confirmed by analytical methods.

Structure and length answer different questions. Kalata B1 can be described both as a molecule containing 29 residues and as a peptide with a cyclic backbone. Neither of these descriptions replaces the other. Similarly, the peptide sequence alone does not convey all the relevant information regarding its three-dimensional organisation. [2]

Classification by biological role

Functional categories include, amongst others, peptide hormones, neuropeptides, peptides involved in the body’s defence mechanisms, and peptides involved in intracellular biochemical processes.

These categories may overlap to some extent, and classification into them should be based on evidence relating to a specific molecule.

The studies cited provide several examples: GLP-1 plays a proven hormonal role in human physiology; LL-37 is being investigated in the context of the body’s defences; whilst glutathione is involved in intracellular redox processes. „Peptide” is a broad chemical description, whilst the functional name describes a specific biological role. [1] [7] [10]

Functional classification should therefore be based on evidence, rather than being inferred solely on the basis of sequence length or the term „peptide” alone.

Classification by origin and method of production

Peptides can also be classified according to their origin or method of production.

Terms such as „of human origin” or „of plant origin” refer to the biological source. „Chemically synthesised”, on the other hand, describes the method of production.

These are not mutually exclusive features. A peptide with a sequence that occurs naturally in the organism can be synthesized in the laboratory.

The synthesis of human neuropeptide Y carried out by Mierke and colleagues clearly illustrates this difference. The sequence was derived from human biology, whilst the experimental material was obtained chemically. This does not mean that every synthetic preparation is identical in every significant respect — which is why the researchers employed analytical methods to characterise the material obtained. [5]

Another distinction relates to the biological mechanism of formation. Many peptide chains are formed through ribosomal synthesis and may subsequently undergo further processing. Other peptides are assembled by specialised enzymatic systems outside the ribosome. Stachelhaus and colleagues directly investigated the formation of peptide bonds by components of such a non-ribosomal system. This distinction describes biosynthesis, rather than a hierarchy of biological significance. [8] [4]

A single peptide may therefore have several correct names at the same time.

For example, the same molecule can be described according to the number of residues, cyclic architecture, biological origin and experimentally confirmed function.

A classification is most useful when the author clearly specifies which property of the molecule they are describing.

What do the terms „bio peptide” and „bioactive peptide” mean?

The term „bio-peptide” is not a sufficiently precise scientific term to be used to identify a specific molecule, sequence or proven activity.

If such a term appears on a label, in a product description or in an online enquiry, the first step is to establish which substance it actually refers to.

The term „bioactive peptide”, that is to say bioactive peptide, usually means that some form of biological activity has been observed under specific conditions.

The most important thing at that point is to determine:

• which molecule was being tested;
• what its sequence and structure were;
• what experimental setup was used;
• what concentration or exposure was studied;
• what effect was measured;
• whether the observation came from a biochemical, cellular, animal or human study.

The inhibition of the signaling response in a plant, the interaction with the bacterial membrane, and the influence on the human hormonal response are different types of biological activity. They cannot be reduced to a single general property called „action”. [6] [7] [1]

Why does the classification not specify the clinical status?

The structural or functional category is not a category of medical approval.

The designation of a molecule as natural, synthetic, cyclic, hormonal or bioactive does not mean that it possesses the evidence required for medical use.

The review by Lau and Dunn on the development of therapeutic peptides shows how individual molecules go through different stages of research and development. This publication is a historical review rather than an up-to-date record of approved products. In this context, it nevertheless demonstrates an important principle: the chemistry of a peptide and its status in clinical development are two separate issues. [11]

A molecule can therefore be of scientific interest, biologically active, or widely studied without being an approved drug at the same time.

Where do peptides occur?

In the human body

Peptides are found in various tissues and biological fluids of humans.

Their location depends on the specific molecule and the process being analyzed. GLP-1 studies have shown its association with the gastrointestinal tract and changes in blood concentrations, while proinsulin studies concern its formation and processing in the pancreas. These are specific examples, not evidence that every peptide exists in all parts of the body.[1][8]

It is also worth distinguishing between three questions:

• Where is the peptide produced?
• Where can it be detected?
• Where does it exert its biological effects?

These places do not have to be the same.

A peptide produced in one tissue can enter the bloodstream and affect another tissue. In turn, other peptides primarily participate in local or intracellular processes.

The mere detection of a peptide in the blood does not, therefore, determine its concentration or biological activity in other tissues.

In plants and microbial systems

The biology of peptides goes far beyond the human organism.

The plant studies included, among other things, signaling related to systemin and the structure of the B1 toxin. In turn, the studies of nonribosomal enzymatic systems concerned another way of assembling peptide molecules.[6][2][4]

These examples show how broad the meaning of the word „peptide” is.

A plant peptide does not automatically become a human hormone, and the experiment involving enzymatic assembly of a molecule is not a clinical study. The biological source and the experimental model remain essential elements of the description.

Interspecies comparisons can provide valuable scientific information, but the results must always be linked to the organism and experimental system in which they were obtained.

In fragments of proteins derived from food

The proteins present in the diet can form smaller peptide fragments during digestion.

However, it is necessary to distinguish between intact protein, protein hydrolysate, and a single purified peptide — these are different materials.

Protein hydrolysate contains products formed as a result of the breakdown of larger proteins into smaller components. Depending on the method of preparation, peptides of various lengths and free amino acids may be present in it.

Iwai and colleagues studied gelatin hydrolysates and identified several peptides derived from collagen in the blood of humans after ingestion. The results show that under certain conditions of the study, it was possible to detect specific fragments. However, they do not prove that all the peptides derived from food pass through the digestive process unchanged or that their detection alone indicates the presence of physiological benefits. [3]

A precise description should therefore indicate the starting material and — if known — the specific fragments detected.

Statements such as „contains protein”, „contains peptides”, and „contains this specific, identified peptide” convey different levels of information.

In materials used in laboratory studies

Peptides can be synthesized so that scientists can study a known sequence, compare its variants, analyze the structure of the molecule, analytical behavior, or specific biochemical hypotheses.

The study of neuropeptide Y combined chemical synthesis with chromatography, mass spectrometry, sequence analysis, and structural methods. This shows that producing a peptide and verifying its properties are related but separate tasks. [5]

Chemical synthesis provides the material that is intended to represent a specific molecular structure. Analytical characterization helps determine whether the material obtained actually possesses the expected properties.

The same principle applies when interpreting a scientific publication: the identity of the material under study is important.

The mere common name of a peptide is not sufficient to assume that each preparation has identical sequence, purity, chemical form or analytical characteristics, or that it has been tested under equivalent conditions.

Why is the sequence, structure, and experimental context important?

Studies of peptides become much easier to interpret when we separate the three basic questions:

What molecule was studied?

This includes its sequence, the number of residues, chemical modifications, and structural properties.

Where and how was it studied?

It is necessary to determine whether the experiment included purified particles, cell cultures, isolated tissues, animals, or humans.

What result was actually measured?

The detection of the molecule, binding to the receptor, interaction with the membrane, gene expression, physiological response, and clinical outcome are different endpoints.

Interpretational problems often arise when evidence from one level is used to justify a claim about another level.

For example:

The peptide was detected in the blood → therefore it provides clinical benefits

it is not automatically a correct conclusion.

Similarly:

The peptide affects the cells in the culture → therefore it causes the same effect in humans

requires additional evidence.

Separating the identity of the molecule, the experimental model, and the actually measured result provides a practical way to read peptide research without drawing conclusions beyond the available data.

Frequently asked questions

1. Do peptids occur naturally in the body?

Yes, many peptides naturally occur in the human body. In studies involving humans, GLP-1 was detected in the intestinal tissue and changes in its concentration were observed in the blood after the intake of nutrients; whereas studies of proinsulin concern the processing of naturally occurring precursor molecules. These results confirm the existence of endogenous peptides, but do not imply that every substance identified as a natural peptide occurs in humans. Some sequences occur in other organisms; some are formed from larger molecules, and others can be created or modified experimentally. Therefore, the natural occurrence must be determined for a specific molecule, and not inferred solely on the word „peptide.” [1] [8]

2. How many amino acids make up a peptide?

A peptide contains at least two linked amino acid residues, but there is no commonly accepted maximum number that unequivocally separates peptides from proteins. In scientific studies, the exact length is often given: B1-calat has 29 residues, and neuropeptide Y — 36; despite the partially overlapping use of the terms peptide and polypeptide. Approximate numerical limits may be useful in education, but they should not be treated as absolute chemical laws. Length helps identify a molecule, but it does not create a universal biological boundary or predict function. Therefore, providing the actual number of residues is more precise than using a rigid threshold. [2] [5]

3. Are peptides the same thing as amino acids?

No. Peptides are joined molecules composed of amino acid residues, whereas free amino acids constitute separate molecular units. Research on nonribosomal peptide synthesis has analyzed the specific reaction mechanisms required to form a product containing peptide binding. This distinction is important because the mere mixing of amino acids does not automatically lead to the formation of a specific sequence. After amino acids are incorporated into a peptide, their sequence and chemical bonds become part of the molecule’s identity. Therefore, peptides must be identified based on their bound structure, and not just on the presence of individual amino acids. [4]

4. What is peptide binding?

Peptide binding is a covalent bond between groups derived from amino acids and forms part of the peptide backbone. From a chemical point of view, it usually links the carbon atom of a carboxyl group from one amino acid to the nitrogen atom from the other. Stachelhaus and colleagues analyzed the role of the enzymatic domain in the formation of such a bond in the nonribosomal system, among other things through modifications that prevented the reaction under investigation. These results concern a specific mechanism of peptide assembly, not all the ways in which it can be formed. The general principle is that peptide bonds link residues in a specific chain, but they do not themselves determine the biological function of that chain. [4]

5. What is a polypeptide?

A polypeptide is a chain containing many amino acid residues linked by peptide bonds. The term partly overlaps with the terms „peptide” and „protein”, rather than denoting a completely separate chemical class. For example, in a publication on the structure of B1 protein, the term „polypeptide” was used for a molecule containing 29 residues. This shows why the term itself is not a precise measure of size. Different fields of science and publications may use the terms “peptide” and “polypeptide” slightly differently. The sequence, number of residues, structure, and biological context therefore provide a more accurate description of the molecule being studied. [2]

6. How are peptides different from proteins?

Peptides and proteins have a common chemistry based on amino acids, whereas the term „protein” usually refers to more elaborate biological molecules formed from one or more polypeptide chains. The terminology is partly overlapping, and a larger precursor can be converted into smaller products, an example being the conversion of proinsulin. Size is part of this distinction, but it should not be treated as a universal boundary. Proteins often form complex structures of higher order, although peptides can also adopt specific three-dimensional conformations. The most useful explanation should therefore point to a specific molecule, the number of its residues, the structure, and its place in the biological process, rather than relying solely on numerical thresholds.[8]

7. Can peptides containing the same amino acids work differently?

Yes. The behavior of a molecule depends not only on the amino acids it contains, but also on their sequence, chemical bonds, modifications, and three-dimensional arrangement. Structural studies of neuropeptide Y and experiments with fragments of the systemin show why the sequence and organization of the molecule require separate analysis. Even peptides containing identical amino acid composition can be different molecules if the residues are arranged in a different order. These studies do not allow predicting the behavior of any possible sequence, therefore two peptides should not be considered equivalent just because their amino acid composition looks similar.[5][6]

8. Does a longer peptide work more effectively?

There is no general rule stating that a longer peptide produces a stronger biological effect. The sequence, structure, molecular target, concentration, stability, and experimental conditions are among the factors that matter. Studies of the systemin fragment showed that the modification of the molecule affected its activity, but did not confirm a universal relationship between length and the strength of the biological effect. A short peptide can perform an important and very specific biochemical function, as exemplified by glutathione, whereas much longer peptides can perform completely different roles. Therefore, length is a parameter describing the molecule. Comparisons of biological effects require direct studies of specific peptides using the same clearly defined endpoint. [6] [10]

9. What does „biologically active peptide” mean?

A bioactive peptide is a peptide for which a specific biological effect has been demonstrated in a specific experimental system. The effect may include a cellular response, interaction with a receptor, interaction with the membrane, biochemical reaction, or a change in a physiological parameter. In studies of LL-37, for example, specific structural properties and interactions with membranes were analyzed. Such results do not automatically confirm clinical action or need to apply to every material that uses the same name. Therefore, „bioactive” should not be understood as a general statement that a peptide provides health benefits. The term only acquires scientific significance when a molecule, experimental system, measured activity, and type of evidence are defined. [7]

10. Are all peptides hormones?

No. A hormone is a functional category that includes some peptides, but not all of them. GLP-1 is an example of a peptide studied as a human intestinal hormone, whereas glutathione is an intracellular tripeptide analyzed in the context of redox processes and its synthesis. Another category consists of peptides associated with the body's defense mechanisms. These examples illustrate very different roles within the same broad chemical class. Calling a molecule a peptide indicates its structure based on amino acids. Terming it a hormone requires additional evidence confirming its signaling role within a specific biological system.[1][10]

11. What is a peptide precursor?

The precursor peptide is a molecule from which a peptide product can be formed as a result of biological processing. A well-known example is proinsulin, in which case intermediate products of conversion, insulin, and peptide C are distinguished. Analytical studies emphasize the necessity of separately measuring these related forms. Processing may involve selective enzymatic cleavage and other molecular changes occurring before the formation of the mature product. Therefore, the precursor should not automatically be attributed all the properties of its final product—its identity, the stage of processing, concentration, location, and measured biological activity require separate evaluation.[8][9]

12. How are linear peptides different from cyclic ones?

Linear peptides have an open backbone, whereas cyclic peptides contain a covalently closed ring formed by the backbone or by side chain linkages. The term „linear” refers to the way the atoms are connected, and does not imply that the molecule must remain physically straight. Kalata B1 is a documented example of a cyclic peptide with a closed backbone and additional disulfide linkages. Its structural analysis shows the organization of this particular molecule, but does not prove that all cyclic peptides behave similarly. The distinction describes primarily the molecular architecture. The influence of such structure on stability, interactions, biological activity, or other properties requires data regarding the specific peptide. [2]

13. Can chemical modifications alter the properties of a peptide?

Yes. Changes in the remaining amino acids, terminal groups, other chemical modifications, or the way the molecule is connected can affect the physical and biological properties of a peptide. The literature on peptide development discusses the use of various structures and strategies in medicinal chemistry, while structural studies highlight the importance of accurately characterizing experimental material. Modifications can potentially affect, among other things, charge, conformation, interactions with other molecules, and susceptibility to chemical and enzymatic transformations. However, modification alone does not guarantee the desired or predictable effect. A modified molecule should be evaluated individually, rather than assuming that all results regarding the original peptide remain valid. [11] [5]

14. Can the naturally occurring peptide also be obtained synthetically?

Yes. Scientists can chemically synthesize the sequence that also occurs naturally. Mierke and colleagues did this for human neuropeptide Y and then used several analytical methods to characterize the resulting material. This shows that the natural occurrence and method of production describe two different aspects of the peptide. „Natural” can refer to the location of the sequence in biology, whereas „synthetic” describes the method of preparing a specific sample. This does not mean that every material with the same name is equivalent — when comparing research materials, the sequence, modifications, chemical form, composition, purity, and analytical characteristics still play a role. [5]

15. Do peptids exist outside the human body?

Yes. Peptides are found in many biological systems, including plants and microorganisms. The studies included, among other things, plant cytokinin, cyclic B1 alkanol, isolated from Oldenlandia affinis and non-ribosomal peptide assembly mechanisms. These examples demonstrate the diversity of origins, structures, and biological contexts. However, they do not imply that a peptide derived from another organism performs the same function in humans. Information regarding the biological source must therefore be separated from claims regarding its action in humans. Interspecies studies may provide important mechanistic information, but transferring results between organisms requires additional evidence. [6] [2] [4]

16. Do all the peptides present in food pass into the blood in unchanged form?

No. Evidence indicating that certain fragments derived from food appear in the blood does not mean that all dietary peptides are absorbed in their unchanged form. Food proteins can undergo significant breakdown during digestion, forming a mixture of peptides and amino acids. Iwai and colleagues identified specific fragments derived from collagen after participants ingested gelatin hydrolysates. The experiment concerned a specific material and measured fragments, not all products containing protein. The mere detection of these fragments also did not confirm any health benefits. Conclusions regarding the absorption of dietary peptides should therefore remain linked to the specific starting material, the analyzed molecules, the methods used, and the experimental conditions. [3]

17. What evidence is needed to determine the action of a peptide?

The type of evidence should correspond to the claim that we want to verify. Structural analysis allows us to determine the characteristics of the molecule; biochemical experiments can investigate mechanisms; cell studies measure specific cell reactions; animal experiments allow us to observe processes throughout the entire organism; and human studies can assess physiological or clinical outcomes. Studies of B1-glucan, zein, and GLP-1 demonstrate different types of scientific questions. No single type of study answers all of them; and the mere detection of a molecule is not the same as demonstrating an effect. Similarly, the effect observed in cells or in animals does not automatically mean the same result in humans. A reliable description should therefore specify what molecule was studied, what experimental model was used, what was actually measured, and what remains uncertain. [2] [6] [1]

18. Does the amino acid sequence determine the identity of a peptide?

The amino acid sequence is a fundamental part of the peptide's identity because it determines the order of residues in the chain. However, the sequence alone may not describe all the important properties of the molecule. Additional information can be provided by modifications at the ends, cyclization, disulfide bridges, and other chemical modifications, as well as the three-dimensional organization. Structural studies of calat B1 and neuropeptide Y show why both the sequence and more advanced molecular characteristics may be important. Therefore, two materials that share the same general name of a peptide should not be automatically considered analytically identical without more detailed characterization. [2] [5]

19. Do synthetic peptides differ from naturally occurring ones?

The terms „synthetic” and „naturally occurring” describe primarily the origin or method of production, rather than automatically another amino acid sequence. The sequence present in the organism can also be prepared chemically, an example of which is the synthesis of human neuropeptide Y. Evaluation of whether two preparations are equivalent in molecular terms requires consideration of their sequence, chemical modifications, structure, composition, and analytical characteristics. Therefore, the word „synthetic” should not be automatically interpreted as meaning biologically different, inferior, better, safer, or more active. These are separate questions requiring separate evidence. [5]

20. Does the detection of a peptide in the blood prove its biological activity?

No. Detection means that the analytical method used identified a peptide or a material associated with it in the sample under study and under certain conditions. Demonstrating biological activity requires additional evidence. Iwai and colleagues detected peptide fragments derived from collagen in the blood of humans after consuming gelatin hydrolysate, but their detection alone did not confirm the health benefits. GLP-1 studies, on the other hand, combined measurements of the peptide with physiological experiments concerning specific responses of the body. These examples illustrate the difference between confirming the presence of a molecule and demonstrating its biological function. [3] [1]

Limitations in the interpretation of general studies on peptides

The first important limitation is that Peptides constitute a huge and very diverse category of molecules. Results regarding one peptide should not be automatically generalized to another peptide with a different sequence, structure, or biological context.

Another limitation is terminology. Terms such as peptide, polypeptide, oligopeptide, protein, or bioactive peptide may be used slightly differently in different fields of science. The actual sequence and structural information are often more precise than the category name itself.

Thirdly, the experimental context matters. A peptide may behave differently depending on the solvent, pH, temperature, concentration, presence of other molecules, the cellular or organismal environment. Therefore, structural observations obtained under specific conditions should not be automatically presented as a universal behavior of the molecule.

Fourthly, biological evidence exists at many levels. Chemical identification, receptor interaction, cellular activity, effects in animals, physiological responses in humans, and clinical results constitute different types of evidence.

Fifthly, natural occurrence does not imply therapeutic usefulness, and chemical synthesis does not determine clinical status. Origin, method of production, biological activity, and medical evidence are separate characteristics.

Finally, detecting a molecule should not be confused with demonstrating its function. Identifying a peptide in blood, tissue, food or other samples confirms its presence under the conditions of the analysis used. Determining the biological function—if any—of the detected molecule requires additional evidence.

Summary

Peptides are molecules made up of amino acids linked by peptide bonds, but this simple definition covers an extremely wide range of structures and biological contexts.

They can consist of only a few residues or form much longer chains. They can be linear, cyclic, additionally crosslinked, naturally produced, enzymatically processed, nonribosomal synthesized, or obtained through chemical synthesis. Some function as biological signals, others participate in the defense of the organism, some are involved in intracellular biochemical processes, and others appear as intermediates or fragments during the processing and breakdown of larger molecules.

For this reason, the term Peptide it should be treated as a name for a broad molecular category, rather than as a prediction of a function.

To properly understand a specific peptide, it is necessary to answer several separate questions:

• What is its amino acid sequence?
• How much is left?
• What is its molecular architecture?
• Does it contain any additional chemical modifications?
• Where does it come from?
• How is it produced or processed?
• In which model was it tested?
• What biological function has actually been demonstrated?
• What kind of evidence supports this conclusion?

The studies discussed in this article show why such distinctions are important. GLP-1 is an example of peptide signaling in humans; calat B1 illustrates the molecular architecture of the molecule; neuropeptide Y illustrates chemical synthesis and structural characteristics; LL-37 is an example of research on defense mechanisms; glutathione represents intracellular peptide chemistry; proinsulin illustrates the processing of precursors; while food-derived collagen fragments remind us why the mere detection of a peptide does not automatically mean biological benefit.[1–10]

The most useful way to understand peptides is therefore not to ask what „peptides” do as a whole group. It is better to first identify a specific molecule and then analyze the evidence regarding its sequence, structure, origin, biological role, and experimental context.

Disclaimer

The article is purely educational and scientifically informative in nature. It explains the chemistry of peptides, the methods of their classification, biological roles, and examples derived from published studies. It does not constitute medical advice, diagnostic guidance, recommendations regarding treatment, information on dosage, advice regarding product selection, or recommendations for the use of any peptide or product containing peptides. The biological activity observed in biochemical, cellular, plant, animal, or other experimental models should not be automatically interpreted as evidence of safety, efficacy, or clinical benefit in humans. Evidence regarding any particular peptide should be evaluated taking into account the molecule under study, the experimental model, the measured result, and the quality of the available studies.

References

[1] Kreymann, B., Williams, G., Ghatei, M. A., & Bloom, S. R. (1987). Glucagon-like peptide-1 7-36: A physiological incretin in man. The Lancet, 2(8571), 1300–1304. https://doi.org/10.1016/s0140-6736(87)91194-9.

[2] Saether, O., Craik, D. J., Campbell, I. D., Sletten, K., Juul, J., & Norman, D. G. (1995). Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry, 34(13), 4147–4158. https://doi.org/10.1021/bi00013a002.

[3] Iwai, K., Hasegawa, T., Taguchi, Y., Morimatsu, F., Sato, K., Nakamura, Y., Higashi, A., Kido, Y., Nakabo, Y., & Ohtsuki, K. (2005). Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. Journal of Agricultural and Food Chemistry, 53(16), 6531–6536. https://doi.org/10.1021/jf050206p.

[4] Stachelhaus, T., Mootz, H. D., Bergendahl, V., & Marahiel, M. A. (1998). Peptide bond formation in nonribosomal peptide biosynthesis. Catalytic role of the condensation domain. Journal of Biological Chemistry, 273(35), 22773–22781. https://doi.org/10.1074/jbc.273.35.22773.

[5] Mierke, D. F., Durr, H., Kessler, H., & Jung, G. (1992). Neuropeptide Y. Optimized solid-phase synthesis and conformational analysis in trifluoroethanol. European Journal of Biochemistry, 206(1), 39–48. https://doi.org/10.1111/j.1432-1033.1992.tb16899.x.

[6] Meindl, T., Boller, T., & Felix, G. (1998). The plant wound hormone systemin binds with the N-terminal part to its receptor but needs the C-terminal part to activate it. The Plant Cell, 10(9), 1561–1570. https://doi.org/10.1105/tpc.10.9.1561.

[7] Xhindoli, D., Morgera, F., Zinth, U., Rizzo, R., Pacor, S., & Tossi, A. (2015). New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine. Biochemical Journal, 465(3), 443–457. https://doi.org/10.1042/BJ20141016.

[8] Linde, S., Welinder, B. S., & Nielsen, J. H. (1993). Analysis of proinsulin and its conversion products by reversed-phase high-performance liquid chromatography. Journal of Chromatography, 614(2), 185–204. https://doi.org/10.1016/0378-4347(93)80309-r.

[9] Davidson, H. W., & Hutton, J. C. (1987). The insulin-secretory-granule carboxypeptidase H. Purification and demonstration of involvement in proinsulin processing. Biochemical Journal, 245(2), 575–582. https://doi.org/10.1042/bj2450575.

[10] Cabral, C. B., Bullock, K. H., Bischoff, D. J., Tompkins, R. G., Yu, Y. M., & Kelleher, J. K. (2008). Estimating glutathione synthesis with deuterated water: A model for peptide biosynthesis. Analytical Biochemistry, 379(1), 40–44. https://doi.org/10.1016/j.ab.2008.04.042.

[11] Lau, J. L., & Dunn, M. K. (2018). Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry, 26(10), 2700–2707. https://doi.org/10.1016/j.bmc.2017.06.052.